[Hemodialysis performance in Center East Tunisia: Compliance and adequacy of biological tests (PHCET study 2014)].

Performance des centres d’hémodialyse au Centre Est Tunisien : conformité et adéquation des examens biologiques (Étude PHCET 2014).
Audit médical Biological tests Dialyse rénale Examens biologiques Healthcare quality Hemodialysis Hemodialysis units Indicateurs qualité santé Medical audit Quality of care indicators Qualité des soins de santé Tunisia Tunisie Unités hospitalières d’hémodialyse

Journal

Revue d'epidemiologie et de sante publique
ISSN: 0398-7620
Titre abrégé: Rev Epidemiol Sante Publique
Pays: France
ID NLM: 7608039

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 31 03 2017
revised: 10 09 2018
accepted: 10 10 2018
pubmed: 17 12 2018
medline: 29 5 2019
entrez: 17 12 2018
Statut: ppublish

Résumé

Determining the performance level of hemodialysis facilities, including an evaluation of biological tests, is a prerequisite for quality assessment of these healthcare structures. The purpose of this work was to evaluate the compliance and adequacy of biological tests performed in 2014 in Center-East Tunisia hemodialysis units. Data were collected using an analysis grid for 15 biological indicators including 11 process items and four results items used to determine the compliance and adequacy rates respectively. This study included 660 hemodialysis patients (sex ratio 1.16; mean age 53.9±15.32 years). A low level of compliance was noted for several biological tests (blood glucose: 0.8%; hemoglobin 34.5%). The rate of adequacy of the biological results was insufficient, especially for anemia (32.7%) and calcium-phosphorus surveillance (41.8%). Intercenter and inter-region variability was noted, both for compliance and for adequacy of biological tests. This study demonstrated low compliance of biological tests performed for hemodialysis patients and the non-adequacy of the results obtained. It is thus urgent to institute a quality management system for biological tests performed in hemodialysis units.

Sections du résumé

BACKGROUND BACKGROUND
Determining the performance level of hemodialysis facilities, including an evaluation of biological tests, is a prerequisite for quality assessment of these healthcare structures.
OBJECTIVE OBJECTIVE
The purpose of this work was to evaluate the compliance and adequacy of biological tests performed in 2014 in Center-East Tunisia hemodialysis units.
METHODS METHODS
Data were collected using an analysis grid for 15 biological indicators including 11 process items and four results items used to determine the compliance and adequacy rates respectively.
RESULTS RESULTS
This study included 660 hemodialysis patients (sex ratio 1.16; mean age 53.9±15.32 years). A low level of compliance was noted for several biological tests (blood glucose: 0.8%; hemoglobin 34.5%). The rate of adequacy of the biological results was insufficient, especially for anemia (32.7%) and calcium-phosphorus surveillance (41.8%). Intercenter and inter-region variability was noted, both for compliance and for adequacy of biological tests.
CONCLUSION CONCLUSIONS
This study demonstrated low compliance of biological tests performed for hemodialysis patients and the non-adequacy of the results obtained. It is thus urgent to institute a quality management system for biological tests performed in hemodialysis units.

Identifiants

pubmed: 30553533
pii: S0398-7620(18)31373-7
doi: 10.1016/j.respe.2018.10.005
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

fre

Sous-ensembles de citation

IM

Pagination

33-41

Informations de copyright

Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Auteurs

M Safer (M)

Unité de recherche « Mesure de performance hospitalière : UR12 SP36 », Direction des systèmes d'information, CHU Sahloul, Sousse, Tunisie. Electronic address: safermouna@yahoo.fr.

I Zemni (I)

Unité de recherche « Mesure de performance hospitalière : UR12 SP36 », Direction des systèmes d'information, CHU Sahloul, Sousse, Tunisie.

F Ben Abderrazak (F)

Unité de recherche « Mesure de performance hospitalière : UR12 SP36 », Direction des systèmes d'information, CHU Sahloul, Sousse, Tunisie.

M Khelil (M)

Unité de recherche « Mesure de performance hospitalière : UR12 SP36 », Direction des systèmes d'information, CHU Sahloul, Sousse, Tunisie.

C Zoghlami (C)

Unité de recherche « Mesure de performance hospitalière : UR12 SP36 », Direction des systèmes d'information, CHU Sahloul, Sousse, Tunisie.

A Ben Abdelaziz (AB)

Unité de recherche « Mesure de performance hospitalière : UR12 SP36 », Direction des systèmes d'information, CHU Sahloul, Sousse, Tunisie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH